These findings are further supported by our analysis of human TCGA data, showing that combined ATRX loss and IDH mutation in astrocytomas yield a pro-inflammatory phenotype relative to IDH mutation alone. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).